Wang Zhongfang, Wan Yanmin, Qiu Chenli, Quiñones-Parra Sergio, Zhu Zhaoqin, Loh Liyen, Tian Di, Ren Yanqin, Hu Yunwen, Zhang Xiaoyan, Thomas Paul G, Inouye Michael, Doherty Peter C, Kedzierska Katherine, Xu Jianqing
1] Shanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, Shanghai 201508, China [2] Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville 3010, Victoria, Australia.
Shanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Medical College, Fudan University, Shanghai 201508, China.
Nat Commun. 2015 May 13;6:6833. doi: 10.1038/ncomms7833.
The avian origin A/H7N9 influenza virus causes high admission rates (>99%) and mortality (>30%), with ultimately favourable outcomes ranging from rapid recovery to prolonged hospitalization. Using a multicolour assay for monitoring adaptive and innate immunity, here we dissect the kinetic emergence of different effector mechanisms across the spectrum of H7N9 disease and recovery. We find that a diversity of response mechanisms contribute to resolution and survival. Patients discharged within 2-3 weeks have early prominent H7N9-specific CD8(+) T-cell responses, while individuals with prolonged hospital stays have late recruitment of CD8(+)/CD4(+) T cells and antibodies simultaneously (recovery by week 4), augmented even later by prominent NK cell responses (recovery >30 days). In contrast, those who succumbed have minimal influenza-specific immunity and little evidence of T-cell activation. Our study illustrates the importance of robust CD8(+) T-cell memory for protection against severe influenza disease caused by newly emerging influenza A viruses.
禽源A/H7N9流感病毒导致高住院率(>99%)和高死亡率(>30%),最终的预后结果从快速康复到长期住院不等。我们使用一种多色检测方法来监测适应性免疫和先天性免疫,在此剖析了H7N9疾病及康复过程中不同效应机制的动态出现情况。我们发现多种反应机制有助于疾病的缓解和患者的存活。在2至3周内出院的患者早期有显著的H7N9特异性CD8(+) T细胞反应,而住院时间延长的个体则在后期同时募集CD8(+)/CD4(+) T细胞和抗体(第4周康复),甚至更晚时因显著的NK细胞反应而增强(康复时间>30天)。相比之下,死亡患者的流感特异性免疫力极低,几乎没有T细胞活化的证据。我们的研究说明了强大的CD8(+) T细胞记忆对于预防由新出现的甲型流感病毒引起的严重流感疾病的重要性。